{
    "Trade/Device Name(s)": [
        "AP-1000 Blood Glucose Monitoring System",
        "AP-1000 Meter",
        "AP-1000 Blood Glucose Test Strips",
        "MAJOR Level I/Level II Control Solution"
    ],
    "Submitter Information": "BESTGEN Biotech Corp.",
    "510(k) Number": "K090389",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062538"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "June 14, 2009",
    "Summary Letter Received Date": "June 18, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AP-1000 Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Capillary action"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strips",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for AP-1000 Blood Glucose Monitoring System utilizing electrochemical biosensor technology for quantitative glucose measurement in fresh capillary whole blood",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertips, for home (OTC) or clinical use by persons with diabetes or healthcare professionals as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}